Matches in Nanopublications for { ?s ?p "[Expression of dominant-negative PPARgamma reverses transcriptional activation of 15-lipoxygenase-2 promoter by enhancing it 202-fold in normal prostate epithelial cells or suppressing it in prostate carcinoma cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 2 of
2
with 100 items per page.
- NP100550.RAOs7oSQRXhIYkG4oLQCRG42oCQ_4vY_rtQUvvgFyb9_k130_assertion description "[Expression of dominant-negative PPARgamma reverses transcriptional activation of 15-lipoxygenase-2 promoter by enhancing it 202-fold in normal prostate epithelial cells or suppressing it in prostate carcinoma cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP100550.RAOs7oSQRXhIYkG4oLQCRG42oCQ_4vY_rtQUvvgFyb9_k130_provenance.
- NP163779.RAbyUlKAc87zdhKEBVPzTANpt88_T4aEC8fHhnq5UKuMc130_assertion description "[Expression of dominant-negative PPARgamma reverses transcriptional activation of 15-lipoxygenase-2 promoter by enhancing it 202-fold in normal prostate epithelial cells or suppressing it in prostate carcinoma cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP163779.RAbyUlKAc87zdhKEBVPzTANpt88_T4aEC8fHhnq5UKuMc130_provenance.